By Aazam AmeenThe World Health Organisation’s (WHO) Emergency Use Listing (EUL) of the Sinopharm vaccine came as a result of a rigorous and painstaking review and assessment process by independent experts from the Technical Advisory Group for Emergency Use Listing (TAG-EUL) and WHO teams, according to the WHO. This comes after a statement made by President Gotabaya Rajapaksa’s Spokesman Kingsley Rathnayaka on Monday (10). In the statement, President Gotabaya Rajapaksa’s Spokesman Kingsley Rathnayaka said that the WHO’s EUL of the Sinopharm vaccine was a result of the President’s online discussion with the Director General of the WHO. “Sri Lanka received a donation of 600,000 doses of Chinese Sinopharm vaccine, which was not earlier approved by the World Health Organisation. However, as a result of a discussion President Gotabaya Rajapaksa held with the Director General of the World Health Organisation (WHO) via Zoom last Friday (7), the WHO on the same evening approved the emergency use of the Sinopharm vaccine,” Rathnayaka stated.

Source: The Nation May 11, 2021 20:07 UTC